Gideon Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,230	Closed	-$562K	–	139
2019 Q4	$562K	Buy	+5,230	New	+$562K	0.19%	161
2018 Q4	–	Sell	-1,725	Closed	-$212K	–	461
2018 Q3	$212K	Sell	1,725 -1,591	-48%	-$196K	0.1%	309
2018 Q2	$326K	Buy	+3,316	New	+$326K	0.16%	237